Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib

  1. Paz-Ares, L.
  2. García Del Muro, X.
  3. Grande, E.
  4. González, P.
  5. Brosa, M.
  6. Díaz, S.
Journal:
Clinical and Translational Oncology

ISSN: 1699-048X,  1699-3055

Year of publication: 2008

Volume: 10

Issue: 12

Pages: 831-839

Type: Article

DOI: 10.1007/S12094-008-0297-3 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus